文献速递技术与安全CT

有过敏史患者碘对比剂不良反应的研究

Adverse reactions to iodinated contrast media in patients with a history of allergies.
PubMed 文献 · Clin Radiol · 2024-12-16

回顾性分析2014年1月至2020年12月有过敏史并接受增强CT的患者,总体不良反应发生率为0.66%(184/27758),严重不良反应为0.05%(14/27758),90.22%(166/184)的不良反应发生在注射后20分钟内,不良反应发生率与碘对比剂种类相关,年龄≥70岁和高血压是非碘对比剂过敏史患者发生不良反应的保护因素。

要点

  • 有过敏史患者增强CT后不良反应总体发生率0.66%,严重不良反应0.05%。
  • 90.22%的不良反应发生在注射后20分钟内,需重点观察该时段。
  • 碘克沙醇在碘对比剂过敏史和非碘对比剂过敏史患者中不良反应发生率均较高。

核心结论

  • 有过敏史患者中,大多数碘对比剂不良反应发生在注射后20分钟内,不良反应发生率与碘对比剂种类相关,年龄≥70岁和高血压是非碘对比剂过敏史患者发生碘对比剂相关不良反应的保护因素。

研究设计与样本

  • 回顾性分析2014年1月至2020年12月期间接受增强CT且有过敏史的患者,共纳入27758例,其中碘对比剂过敏史713例,非碘对比剂过敏史27045例,比较不同组间差异并采用logistic回归分析影响因素。

诊断标准与关键数值

  • 总体不良反应发生率为0.66%(184/27758),严重不良反应发生率为0.05%(14/27758)。
  • 90.22%(166/184)的不良反应发生在注射后20分钟内。
  • 碘对比剂过敏史患者中碘克沙醇不良反应发生率为10.71%(12/112),高于其他碘对比剂。
  • 非碘对比剂过敏史患者中碘克沙醇不良反应发生率为1.1%(46/4172),碘海醇为0.24%(17/7134)。
  • 非碘对比剂过敏史患者中,年龄≥70岁(OR 0.2,P<0.001)和高血压(OR 0.6,P=0.025)为保护因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the prevalence, patterns and influence factors for iodinated contrast media (ICM)-related adverse reaction (AR) in patients with a history of allergies.

METHODS: Patients with a history of allergies who underwent contrast-enhanced CT between January 2014 and December 2020 were enrolled. ICM-related AR and patient information were retrospectively analyzed. χ2 and Student t test were used to compare between different groups, and logistic regression analyses were adopted to investigate influence factors for AR.

RESULTS: 325243 patients performed contrast-enhanced CT examinations. 713 cases with ICM allergy history and 27045 cases with non-ICM allergies history were included. The overall AR incidence was 0.66% (184/27758) and severe AR occurred in 0.05% (14 of 27758). 90.22% (166/184) of AR occurred within 20 minutes after injection. 2 severe AR occurred more than 30 minutes in patients with non-ICM allergies history. Compared with other ICMs, iodixanol was associated with higher incidence of AR in patients with ICM allergy history (10.71%; 12 of 112) and non-ICM allergies history (1.1%; 46 of 4172). Iohexol was associated with lower incidence of AR in patients with non-ICM allergies history (0.24%; 17 of 7134). Age ≥70 years (OR, 0.2; P<0.001) and hypertension (OR, 0.6; P=0.025) were protective factors for ICM-related AR in patients with non-ICM allergies history.

CONCLUSIONS: In patients with a history of allergies, most AR occurred within 20 minutes after injection. The AR incidence was associated with ICM generics. Age ≥70 years and hypertension were protective factors for ICM-related AR in patients with non-ICM allergies history.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Liu H, Li J, et al. Adverse reactions to iodinated contrast media in patients with a history of allergies. Clin Radiol. 2024. PMID: 39837106. doi:10.1016/j.crad.2024.106771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。